DHR vs WST: fair value comparison
Danaher Corporation and West Pharmaceutical Services, Inc. · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, WST currently sits closer to the top of our discount ranking.
| DHR | WST | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $216.07 | $337.47 |
| 12-month range | $175.15–$230.40 | $237.50–$347.94 |
| Sector rank | #68 of 113 Healthcare | #63 of 113 Healthcare |
| Quality grade | B | B |
| Momentum grade | A | A |
| Leverage | Low | Low |
| Margin trend | Expanding | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: DHR fair value analysis · WST fair value analysis